Regeneron Pharmaceuticals logo

Senior Manager, Clinical Scientist, Oncology

Regeneron Pharmaceuticals

Tarrytown, NY; Warren, NJHybridPosted 2 days ago$153,500.00 - $250,500.00
Full TimeSenior LevelClinical DevelopmentBiotechnology
Original posting ↗

Summary

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Job description

Discover your role

  • Lead the planning and execution of clinical studies across early and late phase oncology programs
  • Partner with Medical Directors to bring scientific expertise to study and program design
  • Contribute to protocol development, including the Expanded Synopsis and clinically relevant sections
  • Author and review study documents such as medical monitoring plans, SAPs, informed consents and clinical sections of study reports
  • Perform clinical and medical data review to safeguard patient safety and data integrity
  • Build deep knowledge of the disease area, mechanism of action and drug landscape
  • Connect study design to data analysis to identify critical risks and mitigations
  • Influence and collaborate across a matrix of cross-functional teams, advisory boards and safety monitoring groups

This role requires

  • Bachelor's degree required; advanced degree in life science/healthcare preferred (PhD, MD, PharmD, MSc)
  • 8+ years of pharmaceutical clinical drug development experience
  • Proven knowledge of the drug development process, GCP, ICH guidelines, study design and clinical research methodology
  • Strong medical writing skills
  • Demonstrated ability to influence within and across teams, with clear communication and strong presentation skills
  • Strong analytical, interpersonal and problem-solving skills, including independently resolving complex issues
  • Proven track record of clinical trial process improvements
  • Significant experience working cross-functionally with strong organizational awareness
  • Other levels may be considered depending on experience

Requirements

  • Bachelor's degree required
  • Advanced degree in life science/healthcare preferred (PhD, MD, PharmD, MSc)
  • 8+ years of pharmaceutical clinical drug development experience
  • Proven knowledge of the drug development process, GCP, ICH guidelines, study design and clinical research methodology
  • Strong medical writing skills
  • Demonstrated ability to influence within and across teams
  • Clear communication and strong presentation skills
  • Strong analytical, interpersonal and problem-solving skills
  • Independently resolving complex issues
  • Proven track record of clinical trial process improvements
  • Significant experience working cross-functionally
  • Strong organizational awareness

Benefits

  • Annual bonuses
  • Incentive plans
  • Equity awards
  • Pension or retirement benefits
  • 401(k) company match
  • Health and wellness programs
  • Fitness centers
  • Insurance benefits
  • Paid time off
  • Family support benefits

Company overview

Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.